Cardiff, UK, November 5, 2013: Innovative UK company, Novarum DX, will be showing its leading-edge mobile solutions for the diagnostics industry at MEDICA 2013 (BBI Solutions’ booth F24 in hall 1). Leading the way in the industry’s pursuit for connected health, Novarum’s unique mobile reader combines scientific know-how with smartphone functionality to deliver all the benefits of connected health to lateral flow assay producers and end-users alike, without major platform redevelopment costs.
Speaking from Novarum’s development HQ in Edinburgh, Scotland, Managing Director Neil Polwart comments: “As the industry strives to achieve a connected health system where all aspects of diagnostics and treatment are integrated through seamless processes and technologies, utilising mobile technology is an essential link to reporting diagnostic data back for tracking information at both patient and national levels. We will be at Medica to show the industry how the leading diagnostics companies are using this technology now to achieve this aim.”
The Novarum Reader uses smartphone based software which can be developed to read any lateral flow test, anywhere in the world, without additional hardware. The major advance with the Novarum Reader is how this novel solution increases both the reliability and accuracy of results by removing human error and offers instant access to results either online or via existing data management platforms.
The Novarum Reader can be used to both improve the performance and extend the product life of diagnostics assays by providing a next generation format without the need for high redevelopment costs. It gives the user immediate pass/fail, lab quality results whether they are in the laboratory, doctor’s surgery or out in the field, and all by using the smartphone most healthcare professionals and many patients have in their pocket.
One of the main concerns with a connected health system is security. However with encrypted communications and security protocols which meet or exceed medical industry standards Novarum ensures that not only does its patent protected image processing deliver accurate and reliable results but the information only reaches those who need to know it, protecting patient confidentiality.
Lateral Flow solutions using Novarum software are currently in development by several blue-chip diagnostics organisations and are expected to be launched early 2014. These solutions will cover a broad range of clinical targets, with markets ranging from chronic disease monitoring and infectious disease detection to environmental and employee screening.
Each day of the show, specialists from Novarum will be giving live, on-booth demonstrations of the technology and will be on hand to answer any specific questions developers and manufactures of lateral flow assay may have.